207 related articles for article (PubMed ID: 29797768)
21. Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs.
Moirano SJ; Lima SF; Hume KR; Brodsky EM
Vet Comp Oncol; 2018 Mar; 16(1):E194-E201. PubMed ID: 29239110
[TBL] [Abstract][Full Text] [Related]
22. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004).
Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA
J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855
[TBL] [Abstract][Full Text] [Related]
23. Multiple cutaneous histiocytomas treated with lomustine in a dog.
Maina E; Colombo S; Stefanello D
Vet Dermatol; 2014 Dec; 25(6):559-62, e98-9. PubMed ID: 24963782
[TBL] [Abstract][Full Text] [Related]
24. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
Morgan E; O'Connell K; Thomson M; Griffin A
Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
[TBL] [Abstract][Full Text] [Related]
26. Association of magnetic resonance imaging-based preoperative tumor volume with postsurgical survival time in dogs with primary intracranial glioma.
MacLellan JD; Arnold SA; Dave AC; Hunt MA; Pluhar GE
J Am Vet Med Assoc; 2018 Jan; 252(1):98-102. PubMed ID: 29244602
[TBL] [Abstract][Full Text] [Related]
27. Upfront chemotherapy with CCNU alone for adults' low-grade gliomas: a clinical analysis.
Kaloshi G; Rroji A; Petrela M
J Neurooncol; 2014 Apr; 117(2):373-4. PubMed ID: 24473684
[No Abstract] [Full Text] [Related]
28. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
[TBL] [Abstract][Full Text] [Related]
29. A case series of salvage CCNU in high-grade glioma who have previously received temozolomide from a tertiary care institute in Mumbai.
Patil VM; Abhinav R; Tonse R; Epari S; Gupta T; Jalali R
Indian J Cancer; 2016; 53(4):558-561. PubMed ID: 28485350
[TBL] [Abstract][Full Text] [Related]
30. Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015).
Boostrom BO; Moore AS; DeRegis CJ; Robat C; Freeman K; Thamm DH
J Vet Intern Med; 2017 Jul; 31(4):1074-1080. PubMed ID: 28514049
[TBL] [Abstract][Full Text] [Related]
31. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
[TBL] [Abstract][Full Text] [Related]
32. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
[TBL] [Abstract][Full Text] [Related]
33. Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.
Duffy ME; Anderson CL; Choy K; Fidel JL
Can Vet J; 2018 Feb; 59(2):136-142. PubMed ID: 29386671
[TBL] [Abstract][Full Text] [Related]
34. Treatment of canine mast cell tumors with CCNU (lomustine).
Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM
J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263
[TBL] [Abstract][Full Text] [Related]
35. Case of a miniature dachshund with a primitive neuroectodermal tumor confined to the forebrain region treated with a combination of surgery and chemotherapy.
Nakamoto Y; Yamada A; Uchida K; Matsunaga S; Ozawa T
J Vet Med Sci; 2016 Dec; 78(11):1703-1707. PubMed ID: 27430318
[TBL] [Abstract][Full Text] [Related]
36. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
37. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Blaxill J; Buzzacott P; Finlay J
Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
[TBL] [Abstract][Full Text] [Related]
38. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.
Cooper M; Tsai X; Bennett P
Vet Comp Oncol; 2009 Sep; 7(3):196-206. PubMed ID: 19691648
[TBL] [Abstract][Full Text] [Related]
39. A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
Elliott J; Baines S
Aust Vet J; 2019 Sep; 97(9):308-315. PubMed ID: 31328256
[TBL] [Abstract][Full Text] [Related]
40. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM
Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
